Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Duel(ling) precursors in thymic Treg development.

Maltzman JS.

Sci Immunol. 2019 Jun 7;4(36). pii: eaax9509. doi: 10.1126/sciimmunol.aax9509.

PMID:
31175179
2.

Single cell immune profiling in transplantation research.

Higdon LE, Schaffert S, Khatri P, Maltzman JS.

Am J Transplant. 2019 May;19(5):1278-1287. doi: 10.1111/ajt.15316. Epub 2019 Mar 20. Review.

PMID:
30768832
3.

Optimization of single-cell plate sorting for high throughput sequencing applications.

Higdon LE, Cain CJ, Colden MA, Maltzman JS.

J Immunol Methods. 2019 Mar;466:17-23. doi: 10.1016/j.jim.2018.12.006. Epub 2018 Dec 24.

PMID:
30590019
4.

Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival.

Azad TD, Donato M, Heylen L, Liu AB, Shen-Orr SS, Sweeney TE, Maltzman JS, Naesens M, Khatri P.

JCI Insight. 2018 Jan 25;3(2). pii: 95659. doi: 10.1172/jci.insight.95659. eCollection 2018 Jan 25.

5.

Expanding the Toolkit for the Study of Allospecific B and T Cell Responses.

Higdon LE, Maltzman JS.

Transplantation. 2017 Nov;101(11):2661-2662. doi: 10.1097/TP.0000000000001880. No abstract available.

6.

The outstanding questions in transplantation: It's about timeā€¦.

Azzi J, Raimondi G, Mas V, Riella LV, Elfadawy N, Safa K, Wojciechowski D, Kanak M, Nog R, Maltzman JS, Ford ML, Pober JS, Luo XR, Rothstein D, Miller ML, Matthews D, Burlingham W, Levings M, Heeger P, Higdon L, Gill J, Gill RG, Alegre ML.

Am J Transplant. 2018 Jan;18(1):271-272. doi: 10.1111/ajt.14450. Epub 2017 Sep 2. No abstract available.

7.

Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.

Higdon LE, Trofe-Clark J, Liu S, Margulies KB, Sahoo MK, Blumberg E, Pinsky BA, Maltzman JS.

Am J Transplant. 2017 Aug;17(8):2045-2054. doi: 10.1111/ajt.14227. Epub 2017 Mar 13.

8.

Virtual Global Transplant Laboratory Standard Operating Procedures for Blood Collection, PBMC Isolation, and Storage.

Higdon LE, Lee K, Tang Q, Maltzman JS.

Transplant Direct. 2016 Aug 18;2(9):e101. eCollection 2016 Sep.

9.

HA-ving lymphatics improves lung transplantation.

Maltzman JS, Reed HO, Kahn ML.

J Clin Invest. 2015 Nov 2;125(11):3999-4001. doi: 10.1172/JCI84549. Epub 2015 Oct 20.

10.

Do Mice Need an Order of Fries to Be Relevant for Transplant Studies?

Sawinski D, Maltzman JS.

Am J Transplant. 2015 Sep;15(9):2283-4. doi: 10.1111/ajt.13348. Epub 2015 Jun 16. No abstract available.

11.

Differentially expressed gene transcripts using RNA sequencing from the blood of immunosuppressed kidney allograft recipients.

Dorr C, Wu B, Guan W, Muthusamy A, Sanghavi K, Schladt DP, Maltzman JS, Scherer SE, Brott MJ, Matas AJ, Jacobson PA, Oetting WS, Israni AK.

PLoS One. 2015 May 6;10(5):e0125045. doi: 10.1371/journal.pone.0125045. eCollection 2015.

12.

Regulatory T cells require TCR signaling for their suppressive function.

Schmidt AM, Lu W, Sindhava VJ, Huang Y, Burkhardt JK, Yang E, Riese MJ, Maltzman JS, Jordan MS, Kambayashi T.

J Immunol. 2015 May 1;194(9):4362-70. doi: 10.4049/jimmunol.1402384. Epub 2015 Mar 27.

13.

AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation.

Mengel M, Chong A, Rothstein DM, Zorn E, Maltzman JS.

Am J Transplant. 2014 Mar;14(3):524-30. doi: 10.1111/ajt.12593. Epub 2014 Jan 24.

14.

T-cell costimulatory blockade in organ transplantation.

Maltzman JS, Turka LA.

Cold Spring Harb Perspect Med. 2013 Dec 1;3(12):a015537. doi: 10.1101/cshperspect.a015537. Review.

15.

An obligate cell-intrinsic function for CD28 in Tregs.

Zhang R, Huynh A, Whitcher G, Chang J, Maltzman JS, Turka LA.

J Clin Invest. 2013 Feb;123(2):580-93. doi: 10.1172/JCI65013. Epub 2013 Jan 2.

16.

Homeostatic division is not necessary for antigen-specific CD4+ memory T cell persistence.

Corbo-Rodgers E, Wiehagen KR, Staub ES, Maltzman JS.

J Immunol. 2012 Oct 1;189(7):3378-85. Epub 2012 Sep 5.

17.

Costimulation blockade-a double-edged sword?

Maltzman JS.

Am J Transplant. 2012 Sep;12(9):2269-70. doi: 10.1111/j.1600-6143.2012.04185.x. No abstract available.

18.

Foxp4 is dispensable for T cell development, but required for robust recall responses.

Wiehagen KR, Corbo-Rodgers E, Li S, Staub ES, Hunter CA, Morrisey EE, Maltzman JS.

PLoS One. 2012;7(8):e42273. doi: 10.1371/journal.pone.0042273. Epub 2012 Aug 13.

19.

Leukocyte: tempus fugit vel carpe diem.

Maltzman JS, Bromberg JS.

Am J Transplant. 2012 Jul;12(7):1665. doi: 10.1111/j.1600-6143.2012.04187.x. No abstract available.

20.

Site-specific accumulation of recently activated CD4+ Foxp3+ regulatory T cells following adoptive transfer.

Lieberman SM, Kim JS, Corbo-Rodgers E, Kambayashi T, Maltzman JS, Behrens EM, Turka LA.

Eur J Immunol. 2012 Jun;42(6):1429-35. doi: 10.1002/eji.201142286.

21.

Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo.

Zou T, Satake A, Corbo-Rodgers E, Schmidt AM, Farrar MA, Maltzman JS, Kambayashi T.

J Immunol. 2012 Jul 1;189(1):28-32. doi: 10.4049/jimmunol.1200507. Epub 2012 May 23.

22.

Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells.

Corbo-Rodgers E, Staub ES, Zou T, Smith A, Kambayashi T, Maltzman JS.

Nat Immunol. 2012 Feb 16;13(3):197-8. doi: 10.1038/ni.2232. No abstract available.

23.

Adoptive Treg therapy: closer to the clinic.

Maltzman JS.

Am J Transplant. 2011 Dec;11(12):2545. doi: 10.1111/j.1600-6143.2011.03884.x. No abstract available.

24.

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, Hogquist KA.

J Exp Med. 2011 Jun 6;208(6):1279-89. doi: 10.1084/jem.20110308. Epub 2011 May 23.

25.

Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice.

Falk MJ, Polyak E, Zhang Z, Peng M, King R, Maltzman JS, Okwuego E, Horyn O, Nakamaru-Ogiso E, Ostrovsky J, Xie LX, Chen JY, Marbois B, Nissim I, Clarke CF, Gasser DL.

EMBO Mol Med. 2011 Jul;3(7):410-27. doi: 10.1002/emmm.201100149. Epub 2011 Jun 8.

26.

Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses.

Wu GF, Corbo E, Schmidt M, Smith-Garvin JE, Riese MJ, Jordan MS, Laufer TM, Brown EJ, Maltzman JS.

Eur J Immunol. 2011 Jul;41(7):2064-73. doi: 10.1002/eji.201040809. Epub 2011 Jun 7.

27.

Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88.

Rahman AH, Zhang R, Blosser CD, Hou B, Defranco AL, Maltzman JS, Wherry EJ, Turka LA.

Blood. 2011 Mar 17;117(11):3123-30. doi: 10.1182/blood-2010-11-318485. Epub 2011 Jan 13.

28.

Loss of tonic T-cell receptor signals alters the generation but not the persistence of CD8+ memory T cells.

Wiehagen KR, Corbo E, Schmidt M, Shin H, Wherry EJ, Maltzman JS.

Blood. 2010 Dec 16;116(25):5560-70. doi: 10.1182/blood-2010-06-292458. Epub 2010 Sep 30.

29.

T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool.

Smith-Garvin JE, Burns JC, Gohil M, Zou T, Kim JS, Maltzman JS, Wherry EJ, Koretzky GA, Jordan MS.

Blood. 2010 Dec 16;116(25):5548-59. doi: 10.1182/blood-2010-06-292748. Epub 2010 Sep 16.

30.

Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice.

Shaffer MH, Huang Y, Corbo E, Wu GF, Velez M, Choi JK, Saotome I, Cannon JL, McClatchey AI, Sperling AI, Maltzman JS, Oliver PM, Bhandoola A, Laufer TM, Burkhardt JK.

PLoS One. 2010 Aug 27;5(8):e12404. doi: 10.1371/journal.pone.0012404.

31.

Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.

Liu X, Karnell JL, Yin B, Zhang R, Zhang J, Li P, Choi Y, Maltzman JS, Pear WS, Bassing CH, Turka LA.

J Clin Invest. 2010 Jul;120(7):2497-507. doi: 10.1172/JCI42382.

32.

Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.

Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, Sebzda E, Santore MT, Merianos DJ, Stadtfeld M, Flake AW, Graf T, Skoda R, Maltzman JS, Koretzky GA, Kahn ML.

Blood. 2010 Jul 29;116(4):661-70. doi: 10.1182/blood-2010-02-270876. Epub 2010 Apr 2.

33.

Ablation of SLP-76 signaling after T cell priming generates memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis.

Bushar ND, Corbo E, Schmidt M, Maltzman JS, Farber DL.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):827-31. doi: 10.1073/pnas.0908126107. Epub 2009 Dec 22.

34.

Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production.

Sonnenberg GF, Mangan PR, Bezman NA, Sekiguchi DR, Luning Prak ET, Erikson J, Maltzman JS, Jordan MS, Koretzky GA.

Blood. 2010 Mar 18;115(11):2186-95. doi: 10.1182/blood-2009-08-237438. Epub 2009 Dec 22.

35.

The adapter protein SLP-76 mediates "outside-in" integrin signaling and function in T cells.

Baker RG, Hsu CJ, Lee D, Jordan MS, Maltzman JS, Hammer DA, Baumgart T, Koretzky GA.

Mol Cell Biol. 2009 Oct;29(20):5578-89. doi: 10.1128/MCB.00283-09. Epub 2009 Aug 10.

36.

SLP-76 couples Syk to the osteoclast cytoskeleton.

Reeve JL, Zou W, Liu Y, Maltzman JS, Ross FP, Teitelbaum SL.

J Immunol. 2009 Aug 1;183(3):1804-12. doi: 10.4049/jimmunol.0804206. Epub 2009 Jul 10.

37.

CD3varepsilon: PeRuSing for positive selection.

Maltzman JS, Koretzky GA.

Nat Immunol. 2008 May;9(5):457-9. doi: 10.1038/ni0508-457. No abstract available.

PMID:
18425097
38.

Low oxygen stimulates the immune system.

Maltzman JS, Haase VH.

Kidney Int. 2008 Apr;73(7):797-9. doi: 10.1038/ki.2008.15.

39.

In vivo disruption of T cell development by expression of a dominant-negative polypeptide designed to abolish the SLP-76/Gads interaction.

Jordan MS, Maltzman JS, Kliche S, Shabason J, Smith JE, Obstfeld A, Schraven B, Koretzky GA.

Eur J Immunol. 2007 Oct;37(10):2961-72.

40.

Conditional gene expression: a new tool for the transplantologist.

Maltzman JS, Turka LA.

Am J Transplant. 2007 Apr;7(4):733-40.

41.

Loss of SLP-76 expression within myeloid cells confers resistance to neutrophil-mediated tissue damage while maintaining effective bacterial killing.

Clemens RA, Lenox LE, Kambayashi T, Bezman N, Maltzman JS, Nichols KE, Koretzky GA.

J Immunol. 2007 Apr 1;178(7):4606-14.

42.

Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif.

Seet BT, Berry DM, Maltzman JS, Shabason J, Raina M, Koretzky GA, McGlade CJ, Pawson T.

EMBO J. 2007 Feb 7;26(3):678-89. Epub 2007 Jan 18.

43.

Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development.

Sebzda E, Hibbard C, Sweeney S, Abtahian F, Bezman N, Clemens G, Maltzman JS, Cheng L, Liu F, Turner M, Tybulewicz V, Koretzky GA, Kahn ML.

Dev Cell. 2006 Sep;11(3):349-61.

44.

Are inflammatory cytokines the "evil humors" that increase morbidity and cardiovascular mortality in chronic kidney disease?

Maltzman JS, Berns JS.

Semin Dial. 2005 Sep-Oct;18(5):441-3. No abstract available.

PMID:
16191187
45.

Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection.

Maltzman JS, Kovoor L, Clements JL, Koretzky GA.

J Exp Med. 2005 Oct 3;202(7):893-900. Epub 2005 Sep 26.

46.

Orbital complications after aqueous drainage device procedures.

Marcet MM, Woog JJ, Bellows AR, Mandeville JT, Maltzman JS, Khan J.

Ophthalmic Plast Reconstr Surg. 2005 Jan;21(1):67-9.

PMID:
15677956
47.
48.

Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.

Zhong XP, Hainey EA, Olenchock BA, Jordan MS, Maltzman JS, Nichols KE, Shen H, Koretzky GA.

Nat Immunol. 2003 Sep;4(9):882-90. Epub 2003 Jul 27.

PMID:
12883552
49.

Regulation of hematopoietic cell development and activation by adapter proteins.

Koretzky GA, Abtahian F, Derimanov GS, Dmowski SA, Guerriero A, Jordan MS, Maltzman JS, Olenchock BA, Singer AL, Wu JN, Zhong XP.

Immunol Res. 2003;27(2-3):357-66. Review.

PMID:
12857981
50.

Azathioprine: old drug, new actions.

Maltzman JS, Koretzky GA.

J Clin Invest. 2003 Apr;111(8):1122-4. No abstract available.

Supplemental Content

Loading ...
Support Center